NO20062970L - 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia - Google Patents

7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia

Info

Publication number
NO20062970L
NO20062970L NO20062970A NO20062970A NO20062970L NO 20062970 L NO20062970 L NO 20062970L NO 20062970 A NO20062970 A NO 20062970A NO 20062970 A NO20062970 A NO 20062970A NO 20062970 L NO20062970 L NO 20062970L
Authority
NO
Norway
Prior art keywords
chlorobenzyloxy
benzenesulfonyl
tetrahydro
methoxy
methyl
Prior art date
Application number
NO20062970A
Other languages
English (en)
Inventor
David Clapham
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20062970L publication Critical patent/NO20062970L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Det beskrivelse nye salter av 7-[4-(4-klorbenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-lH-3-benzazepin og farmasøytisk akseptable solvater derav. Videre beskrives farmasøytiske formuleringer, fremgangsmåter for fremstilling av disse samt deres anvendelse i medisin. De nye kjemiske enheter er brukbare ved terapi og særlig som antipsykotiske midler.
NO20062970A 2003-11-28 2006-06-26 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia NO20062970L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds
PCT/EP2004/013416 WO2005051916A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics

Publications (1)

Publication Number Publication Date
NO20062970L true NO20062970L (no) 2006-08-21

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062970A NO20062970L (no) 2003-11-28 2006-06-26 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia

Country Status (18)

Country Link
US (1) US20070275948A1 (no)
EP (1) EP1687279A1 (no)
JP (1) JP2007512285A (no)
KR (1) KR20060103322A (no)
CN (1) CN1906170A (no)
AR (1) AR046719A1 (no)
AU (1) AU2004293179A1 (no)
BR (1) BRPI0417029A (no)
CA (1) CA2547444A1 (no)
GB (1) GB0327740D0 (no)
IL (1) IL175663A0 (no)
IS (1) IS8500A (no)
MA (1) MA28177A1 (no)
NO (1) NO20062970L (no)
RU (1) RU2006122959A (no)
TW (1) TW200528433A (no)
WO (1) WO2005051916A1 (no)
ZA (1) ZA200603781B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
JP5989965B2 (ja) * 2008-01-08 2016-09-07 メルク シャープ エンド ドーム リミテッド ２−｛４−［（３ｓ）−ピペリジン−３−イル］フェニル｝−２ｈ−インダゾール−７−カルボキサミドの薬学的に許容される塩
CA2970502A1 (en) * 2014-12-12 2016-06-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
US11225487B2 (en) 2017-02-17 2022-01-18 Trevena, Inc. 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
US20210347758A1 (en) 2018-10-03 2021-11-11 Tesaro, Inc. Crystalline Forms of Niraparib Freebase
JP2023546729A (ja) * 2020-10-27 2023-11-07 トレベナ・インコーポレイテッド デルタオピオイドモジュレーターの結晶形及び非晶形
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518414A (ja) * 2001-12-21 2005-06-23 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ドーパミン受容体のモジュレーターとしての７−スルホニル−３−ベンゾアゼピン誘導体およびｃｎｓ障害の治療のためのその使用
KR20040081201A (ko) * 2002-02-13 2004-09-20 글락소 그룹 리미티드 항정신병제로서 벤젠술폰아미드 유도체
AR040126A1 (es) * 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento

Also Published As

Publication number Publication date
US20070275948A1 (en) 2007-11-29
JP2007512285A (ja) 2007-05-17
KR20060103322A (ko) 2006-09-28
AR046719A1 (es) 2005-12-21
RU2006122959A (ru) 2008-01-10
CN1906170A (zh) 2007-01-31
ZA200603781B (en) 2007-09-26
BRPI0417029A (pt) 2007-02-06
IL175663A0 (en) 2006-09-05
AU2004293179A1 (en) 2005-06-09
MA28177A1 (fr) 2006-09-01
WO2005051916A1 (en) 2005-06-09
IS8500A (is) 2006-06-08
TW200528433A (en) 2005-09-01
EP1687279A1 (en) 2006-08-09
GB0327740D0 (en) 2003-12-31
CA2547444A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
MY137535A (en) New pyrrolidinium derivatives
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
MY132106A (en) New pyridazin-3(2h)-one derivatives
MXPA03007140A (es) Derivados de carbolina.
MY130803A (en) New quinuclidine amide derivatives
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
ATE327735T1 (de) Taxan-mikroemulsionen
NO20032905L (no) Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister
BR0016543A (pt) Novos derivados de piperidina e piperazina
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
NO20081844L (no) Terapeutiske forbindelser
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
WO2004100865A3 (en) New benzimidazole derivatives
ATE386725T1 (de) Heterocyclylverbindungen
NO20054763L (no) Salter av clopidogrel og fremgangsmate for fremstilling derav
NO20065060L (no) Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20062970L (no) 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia
WO2003031407A3 (en) β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
NO20062491L (no) Benzoksazinderivter og deres anvendelse
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
NO323466B1 (no) Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application